MedPath

Vinmec Research Institute of Stem Cell and Gene Technology

🇻🇳Vietnam
Ownership
Private
Employees
-
Market Cap
-
Website

Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50

Phase 1
Recruiting
Conditions
Female Sexual Dysfunction
Interventions
First Posted Date
2024-12-10
Last Posted Date
2024-12-10
Lead Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Target Recruit Count
50
Registration Number
NCT06726538
Locations
🇻🇳

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

🇻🇳

Vinmec Times City International Hospital, Hanoi, Vietnam

Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy from Brain Hypoxia: a Phase II Clinical Trial

Phase 2
Not yet recruiting
Conditions
Autism Spectrum Disorder
Interventions
Biological: Autologous Bone Marrow Mononuclear Cell Transfusion
Other: Rehabilitation
First Posted Date
2024-10-07
Last Posted Date
2024-10-07
Lead Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Target Recruit Count
58
Registration Number
NCT06629324
Locations
🇻🇳

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia

Phase 1
Recruiting
Conditions
B-Cell Acute Lymphoblastic Leukemia
B-Cell Non Hodgkin Lymphoma
First Posted Date
2023-09-07
Last Posted Date
2023-09-07
Lead Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Target Recruit Count
16
Registration Number
NCT06027957
Locations
🇻🇳

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Autologous Immune Enhancement Therapy (AIET) for Cancer Patients

Phase 1
Completed
Conditions
Patients With Cancer
First Posted Date
2022-08-29
Last Posted Date
2022-08-29
Lead Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Target Recruit Count
60
Registration Number
NCT05520372
Locations
🇻🇳

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Autologous BMNC Infusion for Liver Cirrhosis in Children With BA

Phase 1
Completed
Conditions
Biliary Atresia
First Posted Date
2022-08-26
Last Posted Date
2022-08-26
Lead Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Target Recruit Count
12
Registration Number
NCT05517317
Locations
🇻🇳

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Outcomes of Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequelea in Children With Spina Bifida

Phase 1
Completed
Conditions
Stem Cell Infusion
First Posted Date
2022-07-25
Last Posted Date
2022-07-25
Lead Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Target Recruit Count
11
Registration Number
NCT05472428
Locations
🇻🇳

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency

Phase 1
Recruiting
Conditions
Sexual Dysfunction Male
First Posted Date
2022-04-25
Last Posted Date
2024-06-04
Lead Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Target Recruit Count
158
Registration Number
NCT05345418
Locations
🇻🇳

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis

Phase 1
Completed
Conditions
Liver Cirrhosis
First Posted Date
2022-04-18
Last Posted Date
2024-06-04
Lead Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Target Recruit Count
20
Registration Number
NCT05331872
Locations
🇻🇳

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female

Phase 2
Recruiting
Conditions
Sexual Dysfunction Female
First Posted Date
2022-04-15
Last Posted Date
2024-06-04
Lead Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Target Recruit Count
130
Registration Number
NCT05329662
Locations
🇻🇳

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment

Phase 1
Active, not recruiting
Conditions
Type 1 Diabetes
First Posted Date
2022-04-04
Last Posted Date
2024-12-02
Lead Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Target Recruit Count
10
Registration Number
NCT05308836
Locations
🇻🇳

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

© Copyright 2025. All Rights Reserved by MedPath